TH
REGN icon

Timber Hill’s Regeneron Pharmaceuticals REGN Stock Holding History

Timber Hill’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-9,800
Closed -$4.81M – 892
2017
Q2 		$4.81M Sell
9,800
-25,400
-72% -$11.1M 0.18% 76
2017
Q1 		$13.6M Buy
35,200
+12,900
+58% +$4.78M 0.1% 142
2016
Q4 		$8.19M Sell
22,300
-4,800
-18% -$1.83M 0.04% 365
2016
Q3 		$10.9M Buy
27,100
+11,400
+73% +$4.57M 0.05% 296
2016
Q2 		$5.48M Sell
15,700
-1,400
-8% -$539K 0.03% 504
2016
Q1 		$6.16M Sell
17,100
-11,500
-40% -$4.74M 0.03% 444
2015
Q4 		$15.5M Sell
28,600
-43,300
-60% -$23.5M 0.08% 209
2015
Q3 		$33.4M Buy
71,900
+42,100
+141% +$22.6M 0.14% 130
2015
Q2 		$15.2M Buy
29,800
+3,500
+13% +$1.71M 0.07% 251
2015
Q1 		$11.9M Sell
26,300
-20,600
-44% -$8.73M 0.05% 293
2014
Q4 		$19.2M Buy
46,900
+600
+1% +$236K 0.08% 207
2014
Q3 		$16.7M Buy
46,300
+12,500
+37% +$4.19M 0.07% 227
2014
Q2 		$9.55M Sell
33,800
-13,700
-29% -$4.06M 0.04% 345
2014
Q1 		$14.3M Buy
47,500
+2,000
+4% +$616K 0.06% 259
2013
Q4 		$12.5M Sell
45,500
-26,900
-37% -$7.74M 0.04% 346
2013
Q3 		$22.7M Buy
72,400
+11,800
+19% +$3.1M 0.08% 202
2013
Q2 		$13.6M Buy
+60,600
New +$14.1M 0.05% 321

Other funds holding REGN

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Harris Associates
Harris Associates Chicago, Illinois $75B AUM 11.27% 1-Year Est. Return
Sands Capital Management
Sands Capital Management Arlington, Virginia $25.5B AUM 26.46% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return

Timber Hill's REGN Position: Q2 2018 in Review

Timber Hill sold out of Regeneron Pharmaceuticals (REGN) in Q2 2018, closing a stake of 1,892 shares — an estimated $652K sold.

Timber Hill first reported a position in REGN in Q3 2013 and held it in 7 quarters. The position peaked at $4.01M in Q3 2015. 624 funds tracked by Wall St. Rank hold REGN as of Q2 2018.

  • Timber Hill reported no remaining Regeneron Pharmaceuticals position as of Q2 2018 after selling out during the quarter.
  • Timber Hill sold 1,892 Regeneron Pharmaceuticals shares in Q2 2018, an estimated $652K.
  • Timber Hill first reported a position in Regeneron Pharmaceuticals in Q3 2013 and held it in 7 quarters.
  • Timber Hill's Regeneron Pharmaceuticals position peaked at $4.01M in Q3 2015.
  • 624 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q2 2018.

Based on Timber Hill's 13F filing for Q2 2018, filed 9 Aug 2018.